Open AccessEfficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients
Author(s) -
Carole Rouiller-Braunschweig,
Nicolas Fournier,
Valérie Pittet,
Jean Dudler,
Pierre Michetti
Publication year - 2017
Publication title -
digestion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.882
H-Index - 75
eISSN - 1421-9867
pISSN - 0012-2823
DOI - 10.1159/000482007
Subject(s) - medicine , gastroenterology , ulcerative colitis , methotrexate , inflammatory bowel disease , discontinuation , adverse effect , cohort , disease
Evidence for the effectiveness of methotrexate (MTX) in treating inflammatory bowel disease (IBD) is still incomplete. This study assessed the effectiveness, safety and mucosal healing in IBD patients treated with MTX in the Swiss IBD Cohort.